Target intelligence / Profile preview

Sodium channel protein type VII alpha subunit (SCN7A)

Target
SCN7A
Molecular classification
Ion channel, Voltage-gated sodium channel, Sodium leak channel
01

Overview

SCN7A (Sodium channel protein type VII alpha subunit) is an atypical voltage-gated sodium channel encoded on chromosome 2 that functions primarily as a sodium leak channel and osmosensor, rather than a conventional depolarization-activated channel. Unlike typical sodium channels that respond to changes in membrane voltage, SCN7A is activated by changes in extracellular sodium concentration and maintains sodium ion homeostasis across various tissues and organs. In glial cells of the central nervous system, it plays a critical role in sensing body-fluid sodium levels and controlling salt intake behavior and voluntary water intake by modulating nearby neurons. The channel also contributes to skin barrier homeostasis by mediating sodium influx into keratinocytes. SCN7A is associated with several disease conditions including cervical cancer, epilepsy, and esophageal squamous cell carcinoma, though the mechanistic relationships remain to be fully elucidated. A significant therapeutic challenge is that human SCN7A has not been functionally validated to the same extent as other sodium channels, and the channel is normally locked in an inactive state in human cells due to membrane lipids blocking the pore, limiting direct pharmacological targeting.

Other names
Sodium voltage-gated channel alpha subunit 7Nav2.1Nax channelAtypical sodium channel Nav2.1Sodium channel protein cardiac and skeletal muscle subunit alphaSodium channel, voltage-gated, type VI, alpha polypeptidePutative voltage-gated sodium channel subunit alpha Nax
02

Mechanism of action

SCN7A functions as a **sodium leak channel** rather than a traditional voltage-gated channel. Unlike conventional voltage-gated sodium channels that respond to membrane depolarization, SCN7A is activated by changes in extracellular sodium concentration. The channel allows sodium to flow through the membrane along its concentration gradient, functioning as an osmosensor to regulate sodium homeostasis. In glial cells of the central nervous system, it senses body-fluid sodium levels and modulates nearby neurons to control salt intake behavior and water intake. The channel is generally insensitive to tetrodotoxin in its native state.

03

Biological functions

Sodium ion homeostasis and osmosensingMembrane depolarization during action potentialsRegulation of sodium ion levels in various tissues and organsControl of salt intake behaviorRegulation of voluntary water intake in response to body-fluid sodium levelsSkin barrier homeostasis through sodium influx into keratinocytes
04

Disease associations

Cervical cancer (associated)Epilepsy (associated)Esophageal squamous cell carcinoma (prognostic association)
05

Safety considerations

Limited human functional validation: Despite evidence of sodium-sensing function in mouse models, there is no confirmed functional data for human SCN7A, including in cell culture systems.Unique structural features: SCN7A has atypical voltage-sensing characteristics with fewer positively charged residues in its S4 segments compared to other sodium channels, making it structurally distinct.Hydrophobic gating mechanism: Human SCN7A is normally locked in a nonconductive state due to membrane lipid molecules blocking the pore, requiring specific conditions (such as hypothetical lipid displacement) to become active.Species-specific differences: Low sequence similarity between human and mouse SCN7A proteins compared to other orthologous sodium channel pairs, limiting translational research from rodent models.
06

Interacting drugs

Tetrodotoxin (tetrodotoxin-insensitive, unlike conventional voltage-gated sodium channels)

2 more in the full profile.

07

Biomarkers

No established biomarkers for patient selection or efficacy monitoring are currently documented in the available literature.

Beyond the preview

Go deeper on Sodium channel protein type VII alpha subunit (SCN7A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium channel protein type VII alpha subunit (SCN7A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call